KRAS and colorectal cancer: We recently demonstrated the power of metabonomics to define the specific profiles of human SW48 colorectal cancer cells carrying different KRAS mutations in codons 12, 13, 61 and 146 compared with their wild-type counterpart (Varshavi et al., 2020).